首页 > 最新文献

Annals of Saudi medicine最新文献

英文 中文
Application of digital slide scanning in external quality assessment program on intestinal parasites. 数字切片扫描在肠道寄生虫外部质量评价中的应用。
Pub Date : 2024-11-01 Epub Date: 2024-12-05 DOI: 10.5144/0256-4947.2024.369
Vien Tien Nguyen, Phuc Thi Diem Huynh, Phuong Thi Be Nguyen, Dang Ngoc Tran, Vien Truong Nguyen, Dat Quoc Ngo, Chuon Van Le

Background: Intestinal parasitic infections remain prevalent in Viet Nam. Therefore, ensuring quality assurance in intestinal parasite testing is crucial for screening laboratories. The challenges associated with liquid or glass slide samples necessitate the exploration of digital slide applications, which can offer numerous benefits to program suppliers and participants.

Objectives: Compare the true and concordance rates of digital and glass slides for diagnosis.

Design: Experimental research design.

Materials and methods: In total, 30 medical professionals from 30 hospitals participated in the trial. The sets of slides encompassed a range of densities, including negative and coinfected slides. Seven types of glass slides were selected for scanning and digital slide production.

Main outcome measures: The primary outcomes were true and concordance variables. Secondary outcomes included time sample sending and time completion. The digital slides were uploaded to a secure website for participant access while glass slides were sent individually by mail. Data collection involved participants analyzing specimens and reporting their results using a scoring method based on parasite detection and identification accuracy.

Sample size: 210 glass and digital slide-reading results each.

Results: The mean true rate between original and glass slides diagnosis was 97.6% (range 90.0%-100%), and it slightly increased to 98.1% (range 90.0%-100%) when using digital slides. The average concordance diagnosis rate between glass and digital slides was 99.5%. Importantly, there were no differences in the diagnostic results between glass and digital slides. The findings revealed that the use of digital slides reduced the total time required by approximately 1.1 days compared with that of glass slides.

Conclusion: Altogether, the application of digital slides in the external quality assessment program for intestinal parasites offers convenience for users through online platforms and saves operational time process.

Limitations: The small sample size in this experimental study limited the statistical significance of the comparisons.

背景:肠道寄生虫感染在越南仍然很普遍。因此,确保肠道寄生虫检测的质量对筛查实验室至关重要。与液体或玻璃载玻片样品相关的挑战需要探索数字载玻片应用程序,这可以为程序供应商和参与者提供许多好处。目的:比较数字载玻片和玻璃载玻片诊断的真实率和符合率。设计:实验研究设计。材料与方法:共有来自30家医院的30名医学专业人员参与了试验。各组载玻片包含一系列密度,包括阴性和共感染载玻片。选择7种类型的玻片进行扫描和数字玻片制作。主要结局指标:主要结局为真实和一致性变量。次要结果包括时间样本发送和时间完成。数码幻灯片被上传到一个安全的网站,供参与者访问,而玻璃幻灯片则通过邮件单独发送。数据收集涉及参与者分析标本并使用基于寄生虫检测和识别准确性的评分方法报告其结果。样本量:210个玻璃和数字幻灯片阅读结果。结果:原始玻片与玻片诊断的平均准确率为97.6%(范围90.0% ~ 100%),数字玻片的诊断准确率略高于98.1%(范围90.0% ~ 100%)。玻片与数字玻片的平均诊断率为99.5%。重要的是,玻片和数码玻片的诊断结果没有差异。研究结果显示,与使用玻璃载玻片相比,使用数字载玻片可减少约1.1天的总所需时间。结论:综上所述,数字化幻灯片应用于肠道寄生虫外部质量评估方案,通过在线平台方便了用户,节省了操作时间流程。局限性:本实验研究样本量小,限制了比较的统计学意义。
{"title":"Application of digital slide scanning in external quality assessment program on intestinal parasites.","authors":"Vien Tien Nguyen, Phuc Thi Diem Huynh, Phuong Thi Be Nguyen, Dang Ngoc Tran, Vien Truong Nguyen, Dat Quoc Ngo, Chuon Van Le","doi":"10.5144/0256-4947.2024.369","DOIUrl":"10.5144/0256-4947.2024.369","url":null,"abstract":"<p><strong>Background: </strong>Intestinal parasitic infections remain prevalent in Viet Nam. Therefore, ensuring quality assurance in intestinal parasite testing is crucial for screening laboratories. The challenges associated with liquid or glass slide samples necessitate the exploration of digital slide applications, which can offer numerous benefits to program suppliers and participants.</p><p><strong>Objectives: </strong>Compare the true and concordance rates of digital and glass slides for diagnosis.</p><p><strong>Design: </strong>Experimental research design.</p><p><strong>Materials and methods: </strong>In total, 30 medical professionals from 30 hospitals participated in the trial. The sets of slides encompassed a range of densities, including negative and coinfected slides. Seven types of glass slides were selected for scanning and digital slide production.</p><p><strong>Main outcome measures: </strong>The primary outcomes were true and concordance variables. Secondary outcomes included time sample sending and time completion. The digital slides were uploaded to a secure website for participant access while glass slides were sent individually by mail. Data collection involved participants analyzing specimens and reporting their results using a scoring method based on parasite detection and identification accuracy.</p><p><strong>Sample size: </strong>210 glass and digital slide-reading results each.</p><p><strong>Results: </strong>The mean true rate between original and glass slides diagnosis was 97.6% (range 90.0%-100%), and it slightly increased to 98.1% (range 90.0%-100%) when using digital slides. The average concordance diagnosis rate between glass and digital slides was 99.5%. Importantly, there were no differences in the diagnostic results between glass and digital slides. The findings revealed that the use of digital slides reduced the total time required by approximately 1.1 days compared with that of glass slides.</p><p><strong>Conclusion: </strong>Altogether, the application of digital slides in the external quality assessment program for intestinal parasites offers convenience for users through online platforms and saves operational time process.</p><p><strong>Limitations: </strong>The small sample size in this experimental study limited the statistical significance of the comparisons.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 6","pages":"369-376"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11627036/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advanced trauma life support training outcomes in Saudi Arabia: a four-year multicenter analysis of influential characteristics and factors (2019-2023). 沙特阿拉伯晚期创伤生命支持培训结果:影响特征和因素的四年多中心分析(2019-2023)
Pub Date : 2024-11-01 Epub Date: 2024-12-05 DOI: 10.5144/0256-4947.2024.394
Fayez G Aldarsouni, Hani Alkhulaiwi, Hosam Alruwaite, Shara Alsubaie, Faye Abdulkareem, Norah Alsuabie

Background: The prevalence of trauma necessitates effective training for healthcare providers in Saudi Arabia. The Advanced Trauma Life Support (ATLS) program is pivotal, yet localized success rate data are lacking.

Objectives: Determine the failure rate and identify factors influencing ATLS course success rates among physicianss in Saudi Arabia.

Design: A retrospective cohort.

Setting: Two major accredited ATLS training centers in Riyadh.

Patients and methods: Participants who completed ATLS training at the Trauma Courses Office at the Ministry of National Guard Health Affairs from January 2019 to December 2020, and at the Clinical Skills and Simulation Center at King Saud University Medical City from December 2020 through January 2023. Particpitants were grouped as interns and all physicians other than interns, for the purpose of analysis.

Main outcome measures: Success and failure rates were the primary outcomes, with failure identified as a score of less than 75% or below standard performance in the practical session.

Sample size: 603.

Results: The overall failure rate for the ATLS courses was 36.6%. Analysis revealed age, pre-test scores, and attendance at a refresher course as significant predictors of success. Specifically, general practitioners and OMFS specialists had a higher odds of failing, while general surgeons and trauma-related specialties consultants were more likely to succeed.

Conclusion: ATLS course failure is notably high, with specific specialties and levels demonstrating increased risk. Results indicate a need for tailored pre-course preparation and an extension of the course duration for less experienced participants to improve proficiency, especially for at-risk groups.

Limitations: Retrospective design and other variables, such as emotional status, level of instructors, and level of motivation.

背景:创伤的流行需要对沙特阿拉伯的医疗保健提供者进行有效的培训。高级创伤生命支持(ATLS)项目至关重要,但缺乏本地化的成功率数据。目的:确定沙特阿拉伯医师ATLS课程失败率,并确定影响ATLS课程成功率的因素。设计:回顾性队列研究。设置:两个主要认可的ATLS培训中心在利雅得。患者和方法:参与者于2019年1月至2020年12月在国民警卫队卫生事务部创伤课程办公室完成了ATLS培训,并于2020年12月至2023年1月在沙特国王大学医学城临床技能和模拟中心完成了ATLS培训。为了分析的目的,参与者被分为实习生和除实习生以外的所有医生。主要结果测量:成功率和失败率是主要结果,失败被认为是在实际会话中得分低于75%或低于标准表现。样本量:603。结果:ATLS课程总不合格率为36.6%。分析显示,年龄、考前成绩和参加进修课程是成功的重要预测因素。具体来说,全科医生和OMFS专家失败的几率更高,而普通外科医生和创伤相关专业顾问更有可能成功。结论:ATLS课程失败率明显高,特定专业和水平显示风险增加。结果表明,需要为经验不足的参与者量身定制课前准备,并延长课程时间,以提高熟练程度,特别是对高危群体。局限性:回顾性设计和其他变量,如情绪状态、教师水平和动机水平。
{"title":"Advanced trauma life support training outcomes in Saudi Arabia: a four-year multicenter analysis of influential characteristics and factors (2019-2023).","authors":"Fayez G Aldarsouni, Hani Alkhulaiwi, Hosam Alruwaite, Shara Alsubaie, Faye Abdulkareem, Norah Alsuabie","doi":"10.5144/0256-4947.2024.394","DOIUrl":"10.5144/0256-4947.2024.394","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of trauma necessitates effective training for healthcare providers in Saudi Arabia. The Advanced Trauma Life Support (ATLS) program is pivotal, yet localized success rate data are lacking.</p><p><strong>Objectives: </strong>Determine the failure rate and identify factors influencing ATLS course success rates among physicianss in Saudi Arabia.</p><p><strong>Design: </strong>A retrospective cohort.</p><p><strong>Setting: </strong>Two major accredited ATLS training centers in Riyadh.</p><p><strong>Patients and methods: </strong>Participants who completed ATLS training at the Trauma Courses Office at the Ministry of National Guard Health Affairs from January 2019 to December 2020, and at the Clinical Skills and Simulation Center at King Saud University Medical City from December 2020 through January 2023. Particpitants were grouped as interns and all physicians other than interns, for the purpose of analysis.</p><p><strong>Main outcome measures: </strong>Success and failure rates were the primary outcomes, with failure identified as a score of less than 75% or below standard performance in the practical session.</p><p><strong>Sample size: </strong>603.</p><p><strong>Results: </strong>The overall failure rate for the ATLS courses was 36.6%. Analysis revealed age, pre-test scores, and attendance at a refresher course as significant predictors of success. Specifically, general practitioners and OMFS specialists had a higher odds of failing, while general surgeons and trauma-related specialties consultants were more likely to succeed.</p><p><strong>Conclusion: </strong>ATLS course failure is notably high, with specific specialties and levels demonstrating increased risk. Results indicate a need for tailored pre-course preparation and an extension of the course duration for less experienced participants to improve proficiency, especially for at-risk groups.</p><p><strong>Limitations: </strong>Retrospective design and other variables, such as emotional status, level of instructors, and level of motivation.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 6","pages":"394-407"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11627048/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prospective evaluation of serum and peritoneal fluid markers as indicators of postoperative complications in patients with enteric anastomosis. 血清和腹膜液标志物作为肠吻合术后并发症指标的前瞻性评价。
Pub Date : 2024-11-01 Epub Date: 2024-12-05 DOI: 10.5144/0256-4947.2024.422
Mladen Kasalović, Božidar Odalović, Lazar Mihajlović, Stefan Jakovljević, Zlatan Elek, Gojko Igrutinović, Milena Anđelković, Mirjana Pajčin

Background: Postoperative complications of colorectal cancer surgery contribute to increased morbidity and mortality in patients.

Objectives: Investigate the role of biochemical markers in serum and peritoneal fluid in the development of postoperative complications in patients with enteral anastomosis.

Design: Prospective.

Setting: University hospitals.

Patients and methods: The studied population consisted of patients who underwent surgical treatment with created anastomosis or Hartmann's resection from April 2022 to April 2024, conducted at the Clinical-Hospital Center Kosovska Mitrovica and the University Clinical Center Kragujevac. Spearman's correlation coefficient (rs) was used to test associations between categorical variables.

Main outcome measures: Lactate, albumin, lactate dehydrogenase, and IgA antibodies were monitored as predictors of anastomotic dehiscence and general postoperative complications.

Sample size: 52.

Results: The concentration of lactate in the drain fluid on the third postoperative day was statistically significantly higher in patients who did not develop anastomotic dehiscence (P=.006). The concentration of IgA antibodies in the drain fluid on the third and fifth days post-surgery showed a moderate negative correlation with lactate concentration (rs=-.670, P=.012; rs=-.577, P=.039), repectively. There was a significantly higher concentration of albumin in the drain fluid on the third day post-surgery in patients who developed dehiscence (P=.040), and on the seventh day post-surgery in those who did not develop dehiscence (P=.001). The concentration of LDH on the third day in the drain fluid after surgery was statistically significantly higher in patients who did not develop dehiscence (P=.020). There was a statistically significant difference in lactate concentration in the drain fluid on the third (P<.001) and fifth days (P=.041) post-surgery, as well as in albumin concentration on the third day post-surgery (P=.024) with respect to the development of general postoperative complications.

Conclusion: This study revealed significant differences in the concentrations of lactate, albumin, and LDH in the drain fluid on the third and fifth days post-surgery with respect to the development of complications. These results suggest that monitoring these markers may help in the early identification of patients at risk of complications such as dehiscence.

Limitations: Limited literature on specific aspects of this study, including the absence of a control group, small sample size, and two-center study.

背景:结直肠癌手术后并发症增加了患者的发病率和死亡率。目的:探讨血清及腹膜液生化指标在肠吻合术后并发症发生中的作用。设计:前瞻性。地点:大学医院。患者和方法:研究人群包括2022年4月至2024年4月在科索沃米特罗维察临床医院中心和克拉古耶瓦茨大学临床中心接受手术治疗的人造吻合或哈特曼切除术的患者。Spearman相关系数(rs)用于检验分类变量之间的相关性。主要观察指标:监测乳酸、白蛋白、乳酸脱氢酶和IgA抗体作为吻合口裂和一般术后并发症的预测指标。样本量:52。结果:术后第3天引流液乳酸浓度未发生吻合口裂组高于吻合口裂组(P= 0.006)。术后第3、5天引流液IgA抗体浓度与乳酸浓度呈中度负相关(rs=-)。670, P = .012;rs = -。577, P=.039)。发生裂裂的患者术后第3天引流液中白蛋白浓度显著增高(P= 0.040),未发生裂裂的患者术后第7天引流液中白蛋白浓度显著增高(P= 0.001)。术后第3天引流液中LDH浓度在未发生龟裂的患者中较高,差异有统计学意义(P= 0.020)。术后第3天引流液乳酸浓度(PP= 0.041)和第3天白蛋白浓度(P= 0.024)与一般术后并发症的发生差异有统计学意义。结论:本研究揭示了术后第3天和第5天引流液中乳酸、白蛋白和乳酸脱氢酶的浓度与并发症的发生有显著差异。这些结果表明,监测这些标志物可能有助于早期识别有裂开等并发症风险的患者。局限性:关于本研究特定方面的文献有限,包括缺乏对照组、小样本量和双中心研究。
{"title":"Prospective evaluation of serum and peritoneal fluid markers as indicators of postoperative complications in patients with enteric anastomosis.","authors":"Mladen Kasalović, Božidar Odalović, Lazar Mihajlović, Stefan Jakovljević, Zlatan Elek, Gojko Igrutinović, Milena Anđelković, Mirjana Pajčin","doi":"10.5144/0256-4947.2024.422","DOIUrl":"10.5144/0256-4947.2024.422","url":null,"abstract":"<p><strong>Background: </strong>Postoperative complications of colorectal cancer surgery contribute to increased morbidity and mortality in patients.</p><p><strong>Objectives: </strong>Investigate the role of biochemical markers in serum and peritoneal fluid in the development of postoperative complications in patients with enteral anastomosis.</p><p><strong>Design: </strong>Prospective.</p><p><strong>Setting: </strong>University hospitals.</p><p><strong>Patients and methods: </strong>The studied population consisted of patients who underwent surgical treatment with created anastomosis or Hartmann's resection from April 2022 to April 2024, conducted at the Clinical-Hospital Center Kosovska Mitrovica and the University Clinical Center Kragujevac. Spearman's correlation coefficient (r<sub>s</sub>) was used to test associations between categorical variables.</p><p><strong>Main outcome measures: </strong>Lactate, albumin, lactate dehydrogenase, and IgA antibodies were monitored as predictors of anastomotic dehiscence and general postoperative complications.</p><p><strong>Sample size: </strong>52.</p><p><strong>Results: </strong>The concentration of lactate in the drain fluid on the third postoperative day was statistically significantly higher in patients who did not develop anastomotic dehiscence (<i>P</i>=.006). The concentration of IgA antibodies in the drain fluid on the third and fifth days post-surgery showed a moderate negative correlation with lactate concentration (r<sub>s</sub>=-.670, <i>P</i>=.012; r<sub>s</sub>=-.577, <i>P</i>=.039), repectively. There was a significantly higher concentration of albumin in the drain fluid on the third day post-surgery in patients who developed dehiscence (<i>P</i>=.040), and on the seventh day post-surgery in those who did not develop dehiscence (<i>P</i>=.001). The concentration of LDH on the third day in the drain fluid after surgery was statistically significantly higher in patients who did not develop dehiscence (<i>P</i>=.020). There was a statistically significant difference in lactate concentration in the drain fluid on the third (<i>P</i><.001) and fifth days (<i>P</i>=.041) post-surgery, as well as in albumin concentration on the third day post-surgery (<i>P</i>=.024) with respect to the development of general postoperative complications.</p><p><strong>Conclusion: </strong>This study revealed significant differences in the concentrations of lactate, albumin, and LDH in the drain fluid on the third and fifth days post-surgery with respect to the development of complications. These results suggest that monitoring these markers may help in the early identification of patients at risk of complications such as dehiscence.</p><p><strong>Limitations: </strong>Limited literature on specific aspects of this study, including the absence of a control group, small sample size, and two-center study.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 6","pages":"422-434"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11627050/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatitis A virus infection and seroprevalence, Istanbul, Turkey, 2020-2023. 2020-2023年土耳其伊斯坦布尔甲型肝炎病毒感染和血清阳性率
Pub Date : 2024-11-01 Epub Date: 2024-12-05 DOI: 10.5144/0256-4947.2024.386
Mehmet Karabey, Sema Alacam, Nuran Karabulut, Hayriye Uysal, Alper Gunduz, Ozlem Altuntas Aydina
<p><strong>Background: </strong>Hepatitis A infections continue to be a major global public health problem. The epidemiology and seroprevalence of hepatitis A virus (HAV) have important public health implications. This study aimed to retrospectively examine the hepatitis A cases and hepatitis A seroprevalence in our region in our hospital with the highest number of inpatient and outpatient cases in Istanbul.</p><p><strong>Objective: </strong>Determination of hepatitis A cases and seroprevalence.</p><p><strong>Design: </strong>Cross-sectional.</p><p><strong>Setting: </strong>Tertiary care.</p><p><strong>Patients and methods: </strong>A total of 39 385 individuals who were tested for Anti-HAV IgM and Anti-HAV Total (IgM+IgG) antibodies between May 2020 and September 2023 and were included in this study. Hepatitis A specific IgM and Total (IgM+IgG) antibodies were determined using the enzyme-linked immunosorbent assay method.</p><p><strong>Main outcome measure: </strong>Hepatitis A seroprevalence.</p><p><strong>Sample size: </strong>46 721.</p><p><strong>Results: </strong>The study included a total of 46 721 samples from 39 385 individuals who were tested for hepatitis A serology. The median age of the 39385 individuals included in the study was 28 (interquartile range [IQR]; 22-46), with 58.74% being female and 4.07% (n=1163) being foreign nationals. Reactivity was detected in 91 of the 25 442 patients tested for HAV-IgM. Among these patients, 33 (0.13%) had acute hepatitis A infection, while 58 (0.23%) were considered false positives. Of the acute hepatitis A patients, 13 (0.09%) were women, and 22 (0.80%) were children. Acute hepatitis A was most commonly observed in the 6-9 and 15-18 age groups, with 7 cases each. The seroprevalence rate of hepatitis A was 67.23% among 33 683 individuals. Of those tested for HAV-Total, 13 132 (64.92%) were women, and 2533 (64.88%) were children. The lowest seroprevalence rate among age groups (35.91%) was in the 15-18 age year range, while the highest seroprevalence (98.34%) was detected in individuals aged 60 years and above.</p><p><strong>Conclusion: </strong>With a seroprevalence rate of 67.23%, our region is still considered a medium-endemic area for hepatitis A, and it is crucial to continue administering the HAV vaccine as currently included in the childhood vaccination schedule in our country. Additionally, the significantly low hepatitis A seropositivity, particularly in the 15-18 and 19-24 age groups, indicates the need to promote catch-up vaccination for young adults. Since our study covers a large population, it can serve as a guide regarding the serological status of hepatitis A in Istanbul.</p><p><strong>Limitations: </strong>Since vaccination information for the study population was not available, it was not possible to distinguish between seropositivity due to vaccination or natural immunity. Despite being conducted in Istanbul, a cosmopolitan city, and in the largest city hospital, the results ma
背景:甲型肝炎感染仍然是一个主要的全球公共卫生问题。甲型肝炎病毒(HAV)的流行病学和血清阳性率具有重要的公共卫生意义。本研究旨在回顾性检查我们地区在伊斯坦布尔住院和门诊病例最多的医院的甲型肝炎病例和甲型肝炎血清阳性率。目的:测定甲型肝炎病例及血清阳性率。设计:横断面。环境:三级保健。患者和方法:在2020年5月至2023年9月期间,共有39385人接受了抗hav IgM和抗hav总抗体(IgM+IgG)的检测,并纳入了本研究。采用酶联免疫吸附法检测甲型肝炎特异性IgM和总抗体(IgM+IgG)。主要结局指标:甲型肝炎血清阳性率。样本量:46 721。结果:该研究共包括来自39385人的46 721个样本进行了甲型肝炎血清学检测。纳入研究的39385名个体的中位年龄为28岁(四分位间距[IQR];22-46岁),其中58.74%为女性,4.07% (n=1163)为外籍人士。25442例HAV-IgM患者中有91例检测到反应性。其中33例(0.13%)为急性甲型肝炎感染,58例(0.23%)为假阳性。急性甲型肝炎患者中,女性13例(0.09%),儿童22例(0.80%)。急性甲型肝炎最常见于6-9岁和15-18岁年龄组,各有7例。33 683人甲肝血清阳性率67.23%。在检测HAV-Total的患者中,女性13132例(64.92%),儿童2533例(64.88%)。15-18岁年龄组血清阳性率最低(35.91%),60岁及以上年龄组血清阳性率最高(98.34%)。结论:我区甲肝血清阳性率为67.23%,仍属甲肝中度流行区,应继续接种甲肝疫苗,并将其纳入我国儿童疫苗接种计划。此外,甲型肝炎血清阳性反应明显较低,特别是在15-18岁和19-24岁年龄组,这表明需要促进年轻人接种补种疫苗。由于我们的研究涵盖了大量的人口,它可以作为一个指南,关于在伊斯坦布尔甲型肝炎的血清学状况。局限性:由于无法获得研究人群的疫苗接种信息,因此无法区分由于疫苗接种或自然免疫引起的血清阳性。尽管是在国际大都市伊斯坦布尔和最大的城市医院进行的,但结果可能不能代表整个国家。
{"title":"Hepatitis A virus infection and seroprevalence, Istanbul, Turkey, 2020-2023.","authors":"Mehmet Karabey, Sema Alacam, Nuran Karabulut, Hayriye Uysal, Alper Gunduz, Ozlem Altuntas Aydina","doi":"10.5144/0256-4947.2024.386","DOIUrl":"10.5144/0256-4947.2024.386","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Hepatitis A infections continue to be a major global public health problem. The epidemiology and seroprevalence of hepatitis A virus (HAV) have important public health implications. This study aimed to retrospectively examine the hepatitis A cases and hepatitis A seroprevalence in our region in our hospital with the highest number of inpatient and outpatient cases in Istanbul.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Determination of hepatitis A cases and seroprevalence.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;Cross-sectional.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Setting: &lt;/strong&gt;Tertiary care.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patients and methods: &lt;/strong&gt;A total of 39 385 individuals who were tested for Anti-HAV IgM and Anti-HAV Total (IgM+IgG) antibodies between May 2020 and September 2023 and were included in this study. Hepatitis A specific IgM and Total (IgM+IgG) antibodies were determined using the enzyme-linked immunosorbent assay method.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcome measure: &lt;/strong&gt;Hepatitis A seroprevalence.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Sample size: &lt;/strong&gt;46 721.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The study included a total of 46 721 samples from 39 385 individuals who were tested for hepatitis A serology. The median age of the 39385 individuals included in the study was 28 (interquartile range [IQR]; 22-46), with 58.74% being female and 4.07% (n=1163) being foreign nationals. Reactivity was detected in 91 of the 25 442 patients tested for HAV-IgM. Among these patients, 33 (0.13%) had acute hepatitis A infection, while 58 (0.23%) were considered false positives. Of the acute hepatitis A patients, 13 (0.09%) were women, and 22 (0.80%) were children. Acute hepatitis A was most commonly observed in the 6-9 and 15-18 age groups, with 7 cases each. The seroprevalence rate of hepatitis A was 67.23% among 33 683 individuals. Of those tested for HAV-Total, 13 132 (64.92%) were women, and 2533 (64.88%) were children. The lowest seroprevalence rate among age groups (35.91%) was in the 15-18 age year range, while the highest seroprevalence (98.34%) was detected in individuals aged 60 years and above.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;With a seroprevalence rate of 67.23%, our region is still considered a medium-endemic area for hepatitis A, and it is crucial to continue administering the HAV vaccine as currently included in the childhood vaccination schedule in our country. Additionally, the significantly low hepatitis A seropositivity, particularly in the 15-18 and 19-24 age groups, indicates the need to promote catch-up vaccination for young adults. Since our study covers a large population, it can serve as a guide regarding the serological status of hepatitis A in Istanbul.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;Since vaccination information for the study population was not available, it was not possible to distinguish between seropositivity due to vaccination or natural immunity. Despite being conducted in Istanbul, a cosmopolitan city, and in the largest city hospital, the results ma","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 6","pages":"386-393"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11627051/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility, safety, and outcome of fetoscopic endoluminal tracheal occlusion for severe congenital diaphragmatic hernia at a low case-load center: one center's experience. 低病例负荷中心胎儿镜下腔内气管闭塞治疗严重先天性膈疝的可行性、安全性和结果:一个中心的经验。
Pub Date : 2024-11-01 Epub Date: 2024-12-05 DOI: 10.5144/0256-4947.2024.408
Saud Alshanafey, Wesam I Kurdi, Maha Tulbah, Rubina Ma Khan, Nada Al Sahan, Maisoon Al Mugbel, Fahad Al-Hazzani, Gawaher Almutairi, Ala Jebreel, Maha Al-Nemer

Background: Antenatal fetoscopic endoluminal tracheal occlusion (FETO) has been introduced as an effective intervention to improve the outcome of severe congenital diaphragmatic hernia (CDH).

Objective: We report our early experience with FETO.

Design: A retrospective chart review of case series.

Setting: Tertiary health care center.

Patients and methods: 18-45 years old, with single fetuses diagnosed with left severe CDH (lung-head ratio <1 measured between 27-29 weeks of gestational age (GA) and liver up or observed/expected lung-to-head ratio <25%, normal echocardiogram and karyotype were included. FETO was performed between 28-30 weeks of gestation and removed after 4-6 weeks or at birth during an ex utero intrapartum treatment (EXIT) procedure.

Main outcome measures: FETO represents a viable option for severe type of CDH fetuses with reasonable outcomes. FETO performance in low volume centers may be feasible with reasonable outcomes. Good outcome of postnatal care with no potential antenatal complications may affect FETO adoption in some societies.

Sample size: 5.

Results: 14 pregnant women were referred for assessment and only 7 met the inclusion criteria. Two were excluded initially (late referral and spouse refusal) and a 3rd excluded later due to failure of FETO due to faulty balloons. The median age of the mothers was 28 years and the gestational age was 29 weeks. Median observed/expected lung-to-head ratio was 23%. Among patients who had successful FETO, one had the balloon removed fetoscopically 4 weeks after insertion and one was removed 8 weeks after insertion during an elective EXIT procedure and both have survived. The other two had premature labor after 1 and 5 weeks after FETO and balloon removed during an emergency EXIT procedures, and both died within 24 hours of birth.

Conclusion: FETO represents a viable option for severe type of CDH fetuses with reasonable outcome. FETO performance in a low volume centers may be feasible with reasonable outcomes. Good outcome of postnatal care with no potential antenatal complications may affect FETO adoption in some societies.

Limitations: Retrospective nature of the study may imply inaccuracy, but we believe data from electronic medical records is highly accurate.

背景:产前胎儿镜下腔内气管闭塞术(FETO)被认为是改善重度先天性膈疝(CDH)预后的有效干预手段。目的:我们报告FETO的早期经验。设计:对病例系列进行回顾性图表回顾。环境:三级保健中心。患者和方法:18-45岁,单胎诊断为左重症CDH(肺-头比)主要结局指标:FETO是重症CDH胎儿的可行选择,预后合理。低容量中心的FETO性能在合理的结果下是可行的。在一些社会中,良好的产后护理结果和无潜在的产前并发症可能会影响FETO的采用。样本量:5。结果:14例孕妇转介评估,仅有7例符合纳入标准。其中2例最初被排除(延迟转诊和配偶拒绝),第3例后来被排除,原因是由于有缺陷的气球导致FETO失败。母亲的中位年龄为28岁,孕周为29周。观察/预期肺头比中位数为23%。在成功的FETO患者中,1例在植入后4周通过子宫镜取出球囊,1例在植入后8周通过选择性退出手术取出球囊,均存活。另外两例在紧急退出程序中取出FETO和气囊后1周和5周发生早产,均在出生后24小时内死亡。结论:FETO是重度CDH胎儿可行的选择,结局合理。FETO性能在小容量的中心是可行的,结果是合理的。在一些社会中,良好的产后护理结果和无潜在的产前并发症可能会影响FETO的采用。局限性:研究的回顾性性质可能意味着不准确,但我们相信电子病历的数据是高度准确的。
{"title":"Feasibility, safety, and outcome of fetoscopic endoluminal tracheal occlusion for severe congenital diaphragmatic hernia at a low case-load center: one center's experience.","authors":"Saud Alshanafey, Wesam I Kurdi, Maha Tulbah, Rubina Ma Khan, Nada Al Sahan, Maisoon Al Mugbel, Fahad Al-Hazzani, Gawaher Almutairi, Ala Jebreel, Maha Al-Nemer","doi":"10.5144/0256-4947.2024.408","DOIUrl":"10.5144/0256-4947.2024.408","url":null,"abstract":"<p><strong>Background: </strong>Antenatal fetoscopic endoluminal tracheal occlusion (FETO) has been introduced as an effective intervention to improve the outcome of severe congenital diaphragmatic hernia (CDH).</p><p><strong>Objective: </strong>We report our early experience with FETO.</p><p><strong>Design: </strong>A retrospective chart review of case series.</p><p><strong>Setting: </strong>Tertiary health care center.</p><p><strong>Patients and methods: </strong>18-45 years old, with single fetuses diagnosed with left severe CDH (lung-head ratio <1 measured between 27-29 weeks of gestational age (GA) and liver up or observed/expected lung-to-head ratio <25%, normal echocardiogram and karyotype were included. FETO was performed between 28-30 weeks of gestation and removed after 4-6 weeks or at birth during an ex utero intrapartum treatment (EXIT) procedure.</p><p><strong>Main outcome measures: </strong>FETO represents a viable option for severe type of CDH fetuses with reasonable outcomes. FETO performance in low volume centers may be feasible with reasonable outcomes. Good outcome of postnatal care with no potential antenatal complications may affect FETO adoption in some societies.</p><p><strong>Sample size: </strong>5.</p><p><strong>Results: </strong>14 pregnant women were referred for assessment and only 7 met the inclusion criteria. Two were excluded initially (late referral and spouse refusal) and a 3rd excluded later due to failure of FETO due to faulty balloons. The median age of the mothers was 28 years and the gestational age was 29 weeks. Median observed/expected lung-to-head ratio was 23%. Among patients who had successful FETO, one had the balloon removed fetoscopically 4 weeks after insertion and one was removed 8 weeks after insertion during an elective EXIT procedure and both have survived. The other two had premature labor after 1 and 5 weeks after FETO and balloon removed during an emergency EXIT procedures, and both died within 24 hours of birth.</p><p><strong>Conclusion: </strong>FETO represents a viable option for severe type of CDH fetuses with reasonable outcome. FETO performance in a low volume centers may be feasible with reasonable outcomes. Good outcome of postnatal care with no potential antenatal complications may affect FETO adoption in some societies.</p><p><strong>Limitations: </strong>Retrospective nature of the study may imply inaccuracy, but we believe data from electronic medical records is highly accurate.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 6","pages":"408-413"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11627046/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of semaglutide: real-world tertiary care experience from Saudi Arabia. 西马鲁肽的有效性和安全性:来自沙特阿拉伯的真实三级护理经验。
Pub Date : 2024-11-01 Epub Date: 2024-12-05 DOI: 10.5144/0256-4947.2024.361
Muhammad Imran Butt, Khalid Mania Alkhalifah, Muhammad Riazuddin, Saud Mohammed Almuammar, Salman Mohammed Almuammar, Ghayda Abdulkader Alhifthi, Fahad Wali Ahmed, Samia Mohamed Al Hashim, Najeeb Waheed

Background: Semaglutide, a glucagon-like peptide-1, is an effective antidiabetic drug promoting weight loss and providing cardiovascular protection. The original trials did not include participants from Saudi Arabia; hence, the study's findings are expected to be useful.

Objectives: Explore the efficacy, safety, and favorable effects of once-weekly subcutaneous semaglutide (1 mg) in patients with type 2 diabetes and those who received it as an off-license prescription without having diabetes.

Design: Retrospective review of medical records.

Setting: Department of medicine at our institution.

Patients and methods: This retrospective observational study evaluated patients receiving the glucagon-like peptide-1 analog semaglutide, with the trade name Ozempic. The weight, height, body mass index, blood pressure, and laboratory data, including serum creatinine and hemoglobin A1c (HbA1c) levels and urine albumin/creatinine ratio, were recorded. Moreover, any history of medical comorbidities, such as cardiovascular diseases, cerebrovascular diseases, and heart failure, was documented before and after drug administration.

Main outcome measures: Glycemic and weight loss efficacy.

Sample size: 1007 patients.

Results: The median age of the patients was 57.0 years, comprising 60.28% females. Among them, 955 and 442 patients received the medication for at least 3 and 6 months, respectively. Our results show a 4.4% weight loss and 0.4% improvement in HBA1c in patients with diabetes. Similar results were observed in the patients without diabetes in terms of weight along with a significant decrease in diastolic blood pressure. Our results also show stability in the serum creatinine and urine albumin creatinine ratio. The drug was equally effective in males and females.

Conclusion: Treatment with once-weekly subcutaneous semaglutide (1 mg) led to clinically significant weight loss and improved HbA1c level and cardiometabolic risk factors such as blood pressure.

Limitations: Retrospective design.

背景:Semaglutide是一种胰高血糖素样肽-1,是一种有效的降糖药物,促进体重减轻,并提供心血管保护。最初的试验没有包括来自沙特阿拉伯的参与者;因此,这项研究的发现有望有所帮助。目的:探讨每周一次皮下注射西马鲁肽(1mg)治疗2型糖尿病患者和非糖尿病患者的有效性、安全性和良好效果。设计:对医疗记录进行回顾性审查。地点:本院医学部。患者和方法:这项回顾性观察性研究评估了接受胰高血糖素样肽-1类似物semaglutide(商品名Ozempic)治疗的患者。记录体重、身高、体重指数、血压和实验室数据,包括血清肌酐、血红蛋白A1c (HbA1c)水平和尿白蛋白/肌酐比值。此外,任何医学合并症的历史,如心血管疾病、脑血管疾病和心力衰竭,在给药前后都有记录。主要观察指标:升糖和减肥效果。样本量:1007例。结果:患者中位年龄为57.0岁,女性占60.28%。其中955例患者服药3个月以上,442例患者服药6个月以上。我们的研究结果显示,糖尿病患者体重减轻4.4%,HBA1c改善0.4%。在没有糖尿病的患者中也观察到类似的结果,即体重减轻,舒张压显著降低。我们的结果也显示了血清肌酐和尿白蛋白肌酐比值的稳定性。这种药对男性和女性同样有效。结论:每周一次皮下注射西马鲁肽(1mg)治疗可导致临床显著的体重减轻,改善HbA1c水平和血压等心脏代谢危险因素。局限性:回顾性设计。
{"title":"Efficacy and safety of semaglutide: real-world tertiary care experience from Saudi Arabia.","authors":"Muhammad Imran Butt, Khalid Mania Alkhalifah, Muhammad Riazuddin, Saud Mohammed Almuammar, Salman Mohammed Almuammar, Ghayda Abdulkader Alhifthi, Fahad Wali Ahmed, Samia Mohamed Al Hashim, Najeeb Waheed","doi":"10.5144/0256-4947.2024.361","DOIUrl":"10.5144/0256-4947.2024.361","url":null,"abstract":"<p><strong>Background: </strong>Semaglutide, a glucagon-like peptide-1, is an effective antidiabetic drug promoting weight loss and providing cardiovascular protection. The original trials did not include participants from Saudi Arabia; hence, the study's findings are expected to be useful.</p><p><strong>Objectives: </strong>Explore the efficacy, safety, and favorable effects of once-weekly subcutaneous semaglutide (1 mg) in patients with type 2 diabetes and those who received it as an off-license prescription without having diabetes.</p><p><strong>Design: </strong>Retrospective review of medical records.</p><p><strong>Setting: </strong>Department of medicine at our institution.</p><p><strong>Patients and methods: </strong>This retrospective observational study evaluated patients receiving the glucagon-like peptide-1 analog semaglutide, with the trade name Ozempic. The weight, height, body mass index, blood pressure, and laboratory data, including serum creatinine and hemoglobin A1c (HbA1c) levels and urine albumin/creatinine ratio, were recorded. Moreover, any history of medical comorbidities, such as cardiovascular diseases, cerebrovascular diseases, and heart failure, was documented before and after drug administration.</p><p><strong>Main outcome measures: </strong>Glycemic and weight loss efficacy.</p><p><strong>Sample size: </strong>1007 patients.</p><p><strong>Results: </strong>The median age of the patients was 57.0 years, comprising 60.28% females. Among them, 955 and 442 patients received the medication for at least 3 and 6 months, respectively. Our results show a 4.4% weight loss and 0.4% improvement in HBA1c in patients with diabetes. Similar results were observed in the patients without diabetes in terms of weight along with a significant decrease in diastolic blood pressure. Our results also show stability in the serum creatinine and urine albumin creatinine ratio. The drug was equally effective in males and females.</p><p><strong>Conclusion: </strong>Treatment with once-weekly subcutaneous semaglutide (1 mg) led to clinically significant weight loss and improved HbA1c level and cardiometabolic risk factors such as blood pressure.</p><p><strong>Limitations: </strong>Retrospective design.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 6","pages":"361-368"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11627033/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discharge against medical advice in pediatrics: a 10-year retrospective analysis in a tertiary care center. 儿科不遵医嘱出院:一家三级医疗中心10年回顾性分析。
Pub Date : 2024-11-01 Epub Date: 2024-12-05 DOI: 10.5144/0256-4947.2024.377
Mohammed Albalawi, Kim Sadler, Gassan Abudari, Raghad Tariq Alhuthil, Hamad Hussain Alyami, Atheer Hani Alharbi, Rakan Hazem Badran, Abdulaziz Omar Malhmar

Background: There is still limited data on Discharge Against Medical Advice (DAMA) in the pediatric population. Most research comes from low-and middle-income countries, where the financial burden associated with medical care is often an important reason to leave a healthcare facility prematurely. Discharge against medical advice in the children's population is considered a significant issue that may lead to an increased risk of morbidity and mortality.

Objectives: Describe the characteristics and predictors of DAMA in children over ten years in in Riyadh, Saudi Arabia.

Design: Retrospective.

Setting: Tertiary care center.

Patients and methods: This study included all patients aged <14 years who had DAMA during all admissions between 1 January 2012, and 31 December 2022.

Main outcome measures: Data was retrieved from medical records and included 1) sociodemographic data, 2) medical history and clinical characteristics, 3) utilization of services during the admission leading to DAMA, and 4) interventions provided to prevent departure.

Sample size: 355 DAMA episodes.

Results: Males accounted for 45.4%, and the average age was 4.4 years. The overall DAMA prevalence of was 0.4%. At baseline, 277 children (78%) had at least a chronic illness or severe baseline condition; 59% had a potential life-limiting or life-threatening condition. Reasons for DAMA included disagreement about the treatment plan (14.9%), social reasons (12.6%), and perception that the child's condition improved (5.6%). An increased risk of DAMA recurrence was associated with pre-existing severe or chronic medical conditions (OR: 8.2, P=.004) and a discharge during the treatment phase (OR: 1.9, P=.040).

Conclusions: Despite inconsistent documentation, preventive measures included the involvement of healthcare providers, social services, and patient relations. The study highlights the need for standardized protocols and improved documentation practices to effectively address discharge against medical advice.

Limitations: Needs to moderate documentation quality of DAMA episodes. The study was limited to a single center, which may affect the generalizability. Children might also have presented to receive care in another facility post-DAMA.

背景:在儿科人群中,关于不遵医嘱出院(DAMA)的数据仍然有限。大多数研究来自低收入和中等收入国家,在这些国家,与医疗保健相关的经济负担往往是过早离开医疗机构的一个重要原因。儿童不遵医嘱出院被认为是一个重大问题,可能导致发病率和死亡率增加。目的:描述沙特阿拉伯利雅得10岁以上儿童DAMA的特征和预测因素。设计:回顾性。环境:三级保健中心。患者和方法:本研究纳入了所有年龄的患者。主要结局指标:数据从医疗记录中检索,包括1)社会人口统计数据,2)病史和临床特征,3)入院期间导致DAMA的服务利用情况,以及4)提供的预防离开的干预措施。样本量:355 DAMA剧集。结果:男性占45.4%,平均年龄4.4岁。DAMA的总患病率为0.4%。在基线时,277名儿童(78%)至少患有慢性疾病或严重的基线状况;59%的人有潜在的限制生命或危及生命的情况。DAMA的原因包括对治疗方案的不同意(14.9%)、社会原因(12.6%)和认为孩子的病情有所改善(5.6%)。DAMA复发风险的增加与先前存在的严重或慢性疾病(or: 8.2, P= 0.004)和治疗期间的出院(or: 1.9, P= 0.040)相关。结论:尽管文件不一致,但预防措施包括医疗保健提供者、社会服务和患者关系的参与。该研究强调,需要制定标准化的协议和改进的记录做法,以有效解决不遵医嘱出院的问题。限制:需要适度的DAMA剧集的文档质量。该研究仅限于单一中心,这可能会影响通用性。儿童也可能在dama之后在另一个机构接受照顾。
{"title":"Discharge against medical advice in pediatrics: a 10-year retrospective analysis in a tertiary care center.","authors":"Mohammed Albalawi, Kim Sadler, Gassan Abudari, Raghad Tariq Alhuthil, Hamad Hussain Alyami, Atheer Hani Alharbi, Rakan Hazem Badran, Abdulaziz Omar Malhmar","doi":"10.5144/0256-4947.2024.377","DOIUrl":"10.5144/0256-4947.2024.377","url":null,"abstract":"<p><strong>Background: </strong>There is still limited data on Discharge Against Medical Advice (DAMA) in the pediatric population. Most research comes from low-and middle-income countries, where the financial burden associated with medical care is often an important reason to leave a healthcare facility prematurely. Discharge against medical advice in the children's population is considered a significant issue that may lead to an increased risk of morbidity and mortality.</p><p><strong>Objectives: </strong>Describe the characteristics and predictors of DAMA in children over ten years in in Riyadh, Saudi Arabia.</p><p><strong>Design: </strong>Retrospective.</p><p><strong>Setting: </strong>Tertiary care center.</p><p><strong>Patients and methods: </strong>This study included all patients aged <14 years who had DAMA during all admissions between 1 January 2012, and 31 December 2022.</p><p><strong>Main outcome measures: </strong>Data was retrieved from medical records and included 1) sociodemographic data, 2) medical history and clinical characteristics, 3) utilization of services during the admission leading to DAMA, and 4) interventions provided to prevent departure.</p><p><strong>Sample size: </strong>355 DAMA episodes.</p><p><strong>Results: </strong>Males accounted for 45.4%, and the average age was 4.4 years. The overall DAMA prevalence of was 0.4%. At baseline, 277 children (78%) had at least a chronic illness or severe baseline condition; 59% had a potential life-limiting or life-threatening condition. Reasons for DAMA included disagreement about the treatment plan (14.9%), social reasons (12.6%), and perception that the child's condition improved (5.6%). An increased risk of DAMA recurrence was associated with pre-existing severe or chronic medical conditions (OR: 8.2, <i>P</i>=.004) and a discharge during the treatment phase (OR: 1.9, <i>P</i>=.040).</p><p><strong>Conclusions: </strong>Despite inconsistent documentation, preventive measures included the involvement of healthcare providers, social services, and patient relations. The study highlights the need for standardized protocols and improved documentation practices to effectively address discharge against medical advice.</p><p><strong>Limitations: </strong>Needs to moderate documentation quality of DAMA episodes. The study was limited to a single center, which may affect the generalizability. Children might also have presented to receive care in another facility post-DAMA.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 6","pages":"377-385"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11627037/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of recurrence of risk factors after transcatheter bronchial artery embolization for hemoptysis. 经导管支气管动脉栓塞治疗咯血后风险因素复发分析。
Pub Date : 2024-11-01 Epub Date: 2024-12-05 DOI: 10.5144/0256-4947.2024.414
Yanchao Dong, Jianli An

Background: As a proven and preferred technique for hemoptysis, bronchial artery embolization (BAE) cannot avoid the possibility of postoperative recurrence; however, few studies have examined the causes of hemoptysis recurrence after BAE.

Objectives: Identify the risk factors for hemoptysis recurrence after BAE treatment.

Design: Retrospective.

Setting: Tertiary training and research hospital.

Patients and methods: A retrospective analysis was conducted on 406 patients with hemoptysis, 55 patients who developed with recurrent postembolization hemoptysis, covering the period from January 2011 to January 2021. Single factor analysis and multiple factor logistic regression were used to analyze high-risk factors for hemoptysis recurrence.

Main outcome measures: The incidence and risk factors for recurrence hemoptysis associated with transcatheter BAE.

Sample size: 406 patients.

Results: Multivariate logistic regression analysis showed that preoperative computed tomography angiography (CTA) (odds ratio [OR]: 0.052, 95% CI: 0.012-0.225), tumor-related hemoptysis (OR: 20.753, 95% CI: 6.778-63.545), pleural thickening (OR: 3.168, 95% CI: 1.081-9.286), and bilateral lung lesions (OR: 8.442, 95% CI: 2.449-29.101) had a statistically significant impact on the recurrence of hemoptysis after BAE.

Conclusions: Preoperative CTA serves as a protective factor against hemoptysis recurrence, whereas tumor-related hemoptysis, pleural thickening, and bilateral lung diseases are significant risk factors for hemoptysis recurrence following interventional therapy.

Limitations: This was a retrospective analysis of a single center with a small sample, which may have a certain degree of recall bias when collecting data, thus, reducing the reliability of the results.

背景:支气管动脉栓塞术(支气管动脉栓塞术)是治疗咯血的首选方法,但不能避免术后复发的可能性;然而,很少有研究探讨BAE后咯血复发的原因。目的:探讨BAE治疗后咯血复发的危险因素。设计:回顾性。单位:三级培训和研究医院。患者与方法:回顾性分析2011年1月至2021年1月406例咯血患者,栓塞后复发咯血患者55例。采用单因素分析和多因素logistic回归分析咯血复发的高危因素。主要观察指标:经导管BAE伴咯血复发的发生率及危险因素。样本量:406例患者。结果:多因素logistic回归分析显示,术前ct血管造影(CTA)(比值比[OR]: 0.052, 95% CI: 0.012-0.225)、肿瘤相关性咯血(OR: 20.753, 95% CI: 6.778-63.545)、胸膜增厚(OR: 3.168, 95% CI: 1.081-9.286)、双侧肺病变(OR: 8.442, 95% CI: 2.449-29.101)对BAE术后咯血复发的影响具有统计学意义。结论:术前CTA是预防咯血复发的保护因素,而肿瘤相关性咯血、胸膜增厚、双侧肺部疾病是介入治疗后咯血复发的重要危险因素。局限性:本研究为单中心小样本的回顾性分析,在收集数据时可能存在一定程度的回忆偏倚,从而降低了结果的可靠性。
{"title":"Analysis of recurrence of risk factors after transcatheter bronchial artery embolization for hemoptysis.","authors":"Yanchao Dong, Jianli An","doi":"10.5144/0256-4947.2024.414","DOIUrl":"10.5144/0256-4947.2024.414","url":null,"abstract":"<p><strong>Background: </strong>As a proven and preferred technique for hemoptysis, bronchial artery embolization (BAE) cannot avoid the possibility of postoperative recurrence; however, few studies have examined the causes of hemoptysis recurrence after BAE.</p><p><strong>Objectives: </strong>Identify the risk factors for hemoptysis recurrence after BAE treatment.</p><p><strong>Design: </strong>Retrospective.</p><p><strong>Setting: </strong>Tertiary training and research hospital.</p><p><strong>Patients and methods: </strong>A retrospective analysis was conducted on 406 patients with hemoptysis, 55 patients who developed with recurrent postembolization hemoptysis, covering the period from January 2011 to January 2021. Single factor analysis and multiple factor logistic regression were used to analyze high-risk factors for hemoptysis recurrence.</p><p><strong>Main outcome measures: </strong>The incidence and risk factors for recurrence hemoptysis associated with transcatheter BAE.</p><p><strong>Sample size: </strong>406 patients.</p><p><strong>Results: </strong>Multivariate logistic regression analysis showed that preoperative computed tomography angiography (CTA) (odds ratio [OR]: 0.052, 95% CI: 0.012-0.225), tumor-related hemoptysis (OR: 20.753, 95% CI: 6.778-63.545), pleural thickening (OR: 3.168, 95% CI: 1.081-9.286), and bilateral lung lesions (OR: 8.442, 95% CI: 2.449-29.101) had a statistically significant impact on the recurrence of hemoptysis after BAE.</p><p><strong>Conclusions: </strong>Preoperative CTA serves as a protective factor against hemoptysis recurrence, whereas tumor-related hemoptysis, pleural thickening, and bilateral lung diseases are significant risk factors for hemoptysis recurrence following interventional therapy.</p><p><strong>Limitations: </strong>This was a retrospective analysis of a single center with a small sample, which may have a certain degree of recall bias when collecting data, thus, reducing the reliability of the results.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 6","pages":"414-421"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11627038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of SARS-CoV-2 infection and vaccination on cesarean section outcomes: a retrospective analysis. SARS-CoV-2 感染和疫苗接种对剖腹产结果的影响:回顾性分析。
Pub Date : 2024-09-01 Epub Date: 2024-10-03 DOI: 10.5144/0256-4947.2024.306
Ali Selcuk Yeniocak, Can Tercan, Emrah Dagdeviren, Onur Arabaci, Emine Elif Genc Arabaci

Background: Pregnant individuals have faced unique challenges during the COVID-19 pandemic, necessitating a closer examination of maternal and fetal health outcomes.

Objectives: Investigate the morbidity and mortality associated with SARS-CoV-2 infection among pregnant individuals, considering vaccination status and variant strains.

Design: Retrospective cohort.

Setting: Tertiary state hospital.

Patients and methods: Patients who underwent cesarean sections were categorized into three periods: pre-vaccination (before 31 August 2021), early post-vaccination (from September 2021), and late post-vaccination (aligned with 70% immunization coverage by 2 September 2021). Data collected included demographic information (age, gravidity, parity count, gestational age, newborn APGAR scores), cesarean section indications, chronic diseases, vaccination status, vaccine type and doses, SARS-CoV-2 variant status, ICU admission, and mortality due to COVID-19.

Main outcome measures: ICU admission and mortality rates, focusing on the impact of SARS-CoV-2 infection and vaccination status.

Sample size: 297 COVID PCR-positive symptomatic patients who underwent cesarean sections.

Results: In the pre-vaccination group, there were 13 mortalities (8.1%) compared to 9 (6.6%) post-vaccination (P=.610). Maternal ARDS was seen in 46.2% of pre-vaccination mortalities versus 11.1% post-vaccination (P=.045). COVID-19 delta variant patients had higher ICU admission (80%) and mortality rates (40%). Rates of COVID-19 PCR-positive cesarean sections, ICU admissions, and mortality declined significantly in early (P=.021, P=.004, P=.009), respectively and late post-vaccination periods (P<.001, P<.001, P=.0019), respectively. Vaccinated patients had no ICU admissions or mortality.

Conclusions: Vaccination against COVID-19 is crucial for pregnant individuals as it significantly reduces the risk of severe illness. While vaccines offer substantial protection, the pandemic's acute phase might be waning, yet COVID-19 remains a global threat, particularly in regions with limited vaccine access. Continued vigilance and proactive measures are essential to mitigate ongoing risks and the emergence of new variant strains.

Limitations: Retrospective observational design and the single-center setting, which may affect the generalizability of the findings.

背景:在 COVID-19 大流行期间,孕妇面临着独特的挑战:在 COVID-19 大流行期间,孕妇面临着独特的挑战,因此有必要对孕产妇和胎儿的健康状况进行更深入的研究:调查孕妇感染 SARS-CoV-2 的发病率和死亡率,同时考虑疫苗接种情况和变异毒株:设计:回顾性队列:患者和方法:接受剖宫产的患者:将接受剖腹产手术的患者分为三个时期:接种前(2021 年 8 月 31 日之前)、接种后早期(2021 年 9 月起)和接种后晚期(2021 年 9 月 2 日之前免疫覆盖率达到 70%)。收集的数据包括人口统计学信息(年龄、孕产妇、奇偶数、胎龄、新生儿 APGAR 评分)、剖宫产指征、慢性病、疫苗接种情况、疫苗类型和剂量、SARS-CoV-2 变种情况、ICU 入院情况以及 COVID-19 导致的死亡率:ICU入院率和死亡率,重点关注SARS-CoV-2感染和疫苗接种情况的影响。样本量:297例COVID PCR阳性症状的剖宫产患者:接种前接种组有 13 例死亡(8.1%),而接种后接种组有 9 例死亡(6.6%)(P=.610)。接种前死亡病例中有 46.2% 的产妇出现 ARDS,而接种后为 11.1%(P=.045)。COVID-19 δ变异患者入住重症监护室的比例(80%)和死亡率(40%)均较高。接种后早期(P=.021、P=.004、P=.009)和晚期(PPP=.0019),COVID-19 PCR 阳性剖宫产率、ICU 入院率和死亡率分别显著下降。接种疫苗的患者没有入住重症监护室或死亡:结论:接种 COVID-19 疫苗对孕妇至关重要,因为它能显著降低重症风险。虽然疫苗提供了实质性的保护,大流行的急性期可能正在减弱,但 COVID-19 仍是一个全球性威胁,尤其是在疫苗接种机会有限的地区。继续保持警惕并采取积极措施对于降低持续风险和新变异毒株的出现至关重要:局限性:回顾性观察设计和单中心环境可能会影响研究结果的普遍性。
{"title":"Impact of SARS-CoV-2 infection and vaccination on cesarean section outcomes: a retrospective analysis.","authors":"Ali Selcuk Yeniocak, Can Tercan, Emrah Dagdeviren, Onur Arabaci, Emine Elif Genc Arabaci","doi":"10.5144/0256-4947.2024.306","DOIUrl":"10.5144/0256-4947.2024.306","url":null,"abstract":"<p><strong>Background: </strong>Pregnant individuals have faced unique challenges during the COVID-19 pandemic, necessitating a closer examination of maternal and fetal health outcomes.</p><p><strong>Objectives: </strong>Investigate the morbidity and mortality associated with SARS-CoV-2 infection among pregnant individuals, considering vaccination status and variant strains.</p><p><strong>Design: </strong>Retrospective cohort.</p><p><strong>Setting: </strong>Tertiary state hospital.</p><p><strong>Patients and methods: </strong>Patients who underwent cesarean sections were categorized into three periods: pre-vaccination (before 31 August 2021), early post-vaccination (from September 2021), and late post-vaccination (aligned with 70% immunization coverage by 2 September 2021). Data collected included demographic information (age, gravidity, parity count, gestational age, newborn APGAR scores), cesarean section indications, chronic diseases, vaccination status, vaccine type and doses, SARS-CoV-2 variant status, ICU admission, and mortality due to COVID-19.</p><p><strong>Main outcome measures: </strong>ICU admission and mortality rates, focusing on the impact of SARS-CoV-2 infection and vaccination status.</p><p><strong>Sample size: </strong>297 COVID PCR-positive symptomatic patients who underwent cesarean sections.</p><p><strong>Results: </strong>In the pre-vaccination group, there were 13 mortalities (8.1%) compared to 9 (6.6%) post-vaccination (<i>P</i>=.610). Maternal ARDS was seen in 46.2% of pre-vaccination mortalities versus 11.1% post-vaccination (<i>P</i>=.045). COVID-19 delta variant patients had higher ICU admission (80%) and mortality rates (40%). Rates of COVID-19 PCR-positive cesarean sections, ICU admissions, and mortality declined significantly in early (<i>P</i>=.021, <i>P</i>=.004, <i>P</i>=.009), respectively and late post-vaccination periods (<i>P</i><.001, <i>P</i><.001, <i>P</i>=.0019), respectively. Vaccinated patients had no ICU admissions or mortality.</p><p><strong>Conclusions: </strong>Vaccination against COVID-19 is crucial for pregnant individuals as it significantly reduces the risk of severe illness. While vaccines offer substantial protection, the pandemic's acute phase might be waning, yet COVID-19 remains a global threat, particularly in regions with limited vaccine access. Continued vigilance and proactive measures are essential to mitigate ongoing risks and the emergence of new variant strains.</p><p><strong>Limitations: </strong>Retrospective observational design and the single-center setting, which may affect the generalizability of the findings.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 5","pages":"306-318"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11454973/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142378692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of nocturnal enuresis among children and adults in Saudi Arabia: a systematic review and meta-analysis. 沙特阿拉伯儿童和成人夜尿症患病率:系统回顾和荟萃分析。
Pub Date : 2024-09-01 Epub Date: 2024-10-03 DOI: 10.5144/0256-4947.2024.349
Nehal Ghannam Almutairi, Hadeel Mohammed Alzahrani, Meelaf Ali Alhomrani, Fay Khalid Alowid, Deemah Meshal Alghaith, Rahaf H Almutairi, Maryam Saud Aljaid

Background: Nocturnal enuresis (NE) is defined as any intermittent incontinence while sleeping in a child over the age of 5. This disorder can have emotional and psychological implications. Here, we performed the first meta-analysis to provide an overall assessment of the prevalence of NE and the factors associated with it in Saudi Arabia. We also examined its psychological impact and mothers' behavior in dealing with this disorder.

Patients and methods: A thorough search was conducted on PubMed, Scopus, Cochrane, and Web of Science databases for studies assessing the prevalence of NE. Comprehensive Meta-Analysis Version 3.3 was used to conduct the analysis. We evaluated NE prevalence, NE frequencies, NE by time, social shame and embarrassment in children with NE, and mothers seeking medical advice. A meta-regression analysis was performed to determine the correlation between the frequency of NE and NE in parents, NE in siblings, gender, and age. The quality of the included studies was assessed by Newcastle Ottawa Scale.

Results: Sixteen cross-sectional studies, totaling 14 284 participants, were included. NE prevalence was 24.8% (95% CI: 17, 34). The prevalence of NE one to two times per week was 26.8% (95% CI: 15.1, 43.0), three to four times was 31.8% (95% CI: 18.5, 48.9), and five to seven times was 33.8% (95% CI: 18.2, 54.1). NE occurring at night was 24.4% (95% CI: 22.8, 26.2) and at day and night was 16.6% (95% CI: 15.3, 17.9). A significant difference was found between the regions of Saudi Arabia in the prevalence of NE, with the southern and eastern regions having the highest prevalence and the central region having the lowest prevalence. The overall pooled prevalence of embarrassment and social shame in children with NE was 63% (95% CI: 46, 77). The percentage of mothers seeking medical advice was 54.4% (95% CI: 39.7, 68.3). The prevalence of NE is positively correlated with the prevalence of NE in parents and siblings, but no association was found with males or age.

Conclusion: A quarter of Saudi Arabian children suffer from NE, and it is associated with feelings of embarrassment and social shame. Half of the mothers seek medical counseling. Having parents or siblings with NE increases the likelihood of NE in the child. Future research is needed to corroborate the findings of other risk factors, such as age and gender. Future research will also be required to identify the precise causes or effects within each region that contribute to the varying prevalence of NE.

背景:夜间遗尿症(NE)是指 5 岁以上儿童睡觉时出现的间歇性尿失禁。这种疾病会对情绪和心理造成影响。在此,我们进行了首次荟萃分析,对沙特阿拉伯的 NE 患病率及其相关因素进行了全面评估。我们还研究了这种疾病对母亲的心理影响以及母亲在处理这种疾病时的行为:我们在 PubMed、Scopus、Cochrane 和 Web of Science 数据库中对评估 NE 患病率的研究进行了全面搜索。分析采用了《综合荟萃分析 3.3 版》(Comprehensive Meta-Analysis Version 3.3)。我们评估了NE患病率、NE发生频率、NE发生时间、NE患儿的社会羞耻感和尴尬感以及母亲寻求医疗建议的情况。我们还进行了元回归分析,以确定NE发生频率与父母NE、兄弟姐妹NE、性别和年龄之间的相关性。纳入研究的质量采用纽卡斯尔-渥太华量表(Newcastle Ottawa Scale)进行评估:结果:共纳入了 16 项横断面研究,共有 14 284 人参与。NE患病率为24.8%(95% CI:17-34)。每周一至两次的NE发生率为26.8%(95% CI:15.1,43.0),三至四次为31.8%(95% CI:18.5,48.9),五至七次为33.8%(95% CI:18.2,54.1)。夜间发生 NE 的比例为 24.4%(95% CI:22.8,26.2),昼夜发生 NE 的比例为 16.6%(95% CI:15.3,17.9)。研究发现,沙特阿拉伯各地区的近视患病率存在明显差异,南部和东部地区的患病率最高,而中部地区的患病率最低。在患有 NE 的儿童中,窘迫感和社交羞耻感的总患病率为 63%(95% CI:46%-77%)。寻求医疗建议的母亲比例为 54.4% (95% CI: 39.7, 68.3)。近视患病率与父母和兄弟姐妹的近视患病率呈正相关,但与男性或年龄没有关联:结论:四分之一的沙特阿拉伯儿童患有NE,而且NE与尴尬和社会羞耻感有关。半数母亲会寻求医疗咨询。父母或兄弟姐妹患有 NE 会增加儿童患 NE 的可能性。今后的研究需要对年龄和性别等其他风险因素的研究结果加以证实。此外,未来的研究还需要确定每个地区导致 NE 发病率不同的确切原因或影响。
{"title":"Prevalence of nocturnal enuresis among children and adults in Saudi Arabia: a systematic review and meta-analysis.","authors":"Nehal Ghannam Almutairi, Hadeel Mohammed Alzahrani, Meelaf Ali Alhomrani, Fay Khalid Alowid, Deemah Meshal Alghaith, Rahaf H Almutairi, Maryam Saud Aljaid","doi":"10.5144/0256-4947.2024.349","DOIUrl":"10.5144/0256-4947.2024.349","url":null,"abstract":"<p><strong>Background: </strong>Nocturnal enuresis (NE) is defined as any intermittent incontinence while sleeping in a child over the age of 5. This disorder can have emotional and psychological implications. Here, we performed the first meta-analysis to provide an overall assessment of the prevalence of NE and the factors associated with it in Saudi Arabia. We also examined its psychological impact and mothers' behavior in dealing with this disorder.</p><p><strong>Patients and methods: </strong>A thorough search was conducted on PubMed, Scopus, Cochrane, and Web of Science databases for studies assessing the prevalence of NE. Comprehensive Meta-Analysis Version 3.3 was used to conduct the analysis. We evaluated NE prevalence, NE frequencies, NE by time, social shame and embarrassment in children with NE, and mothers seeking medical advice. A meta-regression analysis was performed to determine the correlation between the frequency of NE and NE in parents, NE in siblings, gender, and age. The quality of the included studies was assessed by Newcastle Ottawa Scale.</p><p><strong>Results: </strong>Sixteen cross-sectional studies, totaling 14 284 participants, were included. NE prevalence was 24.8% (95% CI: 17, 34). The prevalence of NE one to two times per week was 26.8% (95% CI: 15.1, 43.0), three to four times was 31.8% (95% CI: 18.5, 48.9), and five to seven times was 33.8% (95% CI: 18.2, 54.1). NE occurring at night was 24.4% (95% CI: 22.8, 26.2) and at day and night was 16.6% (95% CI: 15.3, 17.9). A significant difference was found between the regions of Saudi Arabia in the prevalence of NE, with the southern and eastern regions having the highest prevalence and the central region having the lowest prevalence. The overall pooled prevalence of embarrassment and social shame in children with NE was 63% (95% CI: 46, 77). The percentage of mothers seeking medical advice was 54.4% (95% CI: 39.7, 68.3). The prevalence of NE is positively correlated with the prevalence of NE in parents and siblings, but no association was found with males or age.</p><p><strong>Conclusion: </strong>A quarter of Saudi Arabian children suffer from NE, and it is associated with feelings of embarrassment and social shame. Half of the mothers seek medical counseling. Having parents or siblings with NE increases the likelihood of NE in the child. Future research is needed to corroborate the findings of other risk factors, such as age and gender. Future research will also be required to identify the precise causes or effects within each region that contribute to the varying prevalence of NE.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 5","pages":"349-359"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11454959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142378695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Saudi medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1